Skip to main content

What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?

Supportive Care in Cancer volume 12, pages 3–5 (2004)Cite this article

Abstract

Since about 1970 scalp cooling has been used to prevent chemotherapy-induced hair loss, one of the most common and emotionally distressing side effects of cancer therapy. Generally accepted opinions, uncertainty and controversy, topics to study and recommendations for improving the results of scalp cooling are the subjects of this article which was also presented at the MASCC Symposium, June 2003, Berlin.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Author information

Affiliations

  1. Lissevenlaan 13, 5582 KB, Waalre, The Netherlands

    Wim P. M. Breed

Authors
  1. Wim P. M. Breed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wim P. M. Breed.

Additional information

This work was presented as an invited lecture at the 15th International Symposium Supportive Care in Cancer, Berlin, Germany, 18–21 June 2003

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Breed, W.P.M. What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?. Support Care Cancer 12, 3–5 (2004). https://doi.org/10.1007/s00520-003-0551-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-003-0551-8

Keywords

  • Scalp cooling
  • Hypothermia
  • Cold cap
  • Chemotherapy-induced hair loss
  • Alopecia